Texas Instruments Incorporated
$247.19B- Market cap
- $236.37B
- Debt
- +$14.05B
- Cash
- −$3.23B
Capital structure 94% equity / 6% debt · EV / Revenue 13.98x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $236.37B · View financials
Snapshot Sep 10, 2026, 4:00 PM ET
Decision snapshot: TXN stock price at discount vs MCHP $258.82 current versus $1.77K implied using P/E multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at MCHP's multiple
Implied fair value · at TXN's multiple
Snapshot Sep 10, 2026, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Reported gross margin
Operating income + D&A
Lower is better
Lower P/E
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
Nine period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Capital structure 94% equity / 6% debt · EV / Revenue 13.98x
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
TEXAS INSTRUMENTS INCORPORATED · implied price per share
Bear
$24.46
Base
$29.37
Bull
$38.11
MICROCHIP TECHNOLOGY INCORPORATED · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe TXN's superior profitability (net income $4.8B, ROIC 23.1%) and EBITDA generation (EBITDA margin 45.9%) will persist and justify a premium to peers, then maintain or accumulate up to the midpoint of the historical band because the stock trades inside its historical range ($194.00 - $237.11) despite being ~35% above MCHP-implied price; otherwise, trim exposure as the P/E (41.5x) leaves the stock vulnerable to earnings disappointments.
TXN's current price ($215.55) is ~35% above MCHP-implied price ($159.87) and therefore reflects a premium to Microchip-based valuation. The stock is inside TXN's historical band ($194.00 - $237.11), roughly mid‑range, suggesting the market is paying up but not beyond recent highs.
Supporting Metrics